Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Rectal Cancer | Research

Risk prediction of second primary malignancies in patients after rectal cancer: analysis based on SEER Program

Authors: Yong-Chao Sun, Zi-Dan Zhao, Na Yao, Yu-Wen Jiao, Jia-Wen Zhang, Yue Fu, Wei-Hai Shi

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

This study will focus on exploring the clinical characteristics of rectal cancer (RC) patients with Second Primary Malignancies (SPMs) and constructing a prognostic nomogram to provide clinical treatment decisions.

Methods

We determined the association between risk factors and overall survival (OS) while establishing a nomogram to forecast the further OS status of these patients via Cox regression analysis. Finally, we evaluated the performance of the prognostic nomogram to predict further OS status.

Results

Nine parameters were identified to establish the prognostic nomogram in this study, and, the C-index of the training set and validation set was 0.691 (95%CI, 0.662–0.720) and 0.731 (95%CI, 0.676–0.786), respectively. The calibration curve showed a high agreement between the predicted and actual results, and the receiver operating characteristic (ROC) curves verified the superiority of our model for clinical usefulness. In addition, the nomogram classification could more precisely differentiate risk subgroups and improved the discrimination of SPMs’ prognosis.

Conclusions

We systematically explored the clinical characteristics of SPMs after RC and constructed a satisfactory nomogram.
Appendix
Available only for authorised users
Literature
12.
go back to reference Lee Y-T, Liu C-J, Hu Y-W, Teng C-J, Tzeng C-H, Yeh C-M, et al. Incidence of second primary malignancies following colorectal Cancer: a distinct pattern of occurrence between Colon and rectal cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based cohort of 98,876 patients in Taiwan. Med (Baltim). 2015;94(26):e1079. https://doi.org/10.1097/MD.0000000000001079.CrossRef Lee Y-T, Liu C-J, Hu Y-W, Teng C-J, Tzeng C-H, Yeh C-M, et al. Incidence of second primary malignancies following colorectal Cancer: a distinct pattern of occurrence between Colon and rectal cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based cohort of 98,876 patients in Taiwan. Med (Baltim). 2015;94(26):e1079. https://​doi.​org/​10.​1097/​MD.​0000000000001079​.CrossRef
14.
go back to reference Andrieu N, Launoy G, Guillois R, Ory-Paoletti C, Gignoux M. Estimation of the familial relative risk of cancer by site from a french population based family study on colorectal cancer (CCREF study). Gut. 2004;53(9):1322–8.CrossRefPubMedPubMedCentral Andrieu N, Launoy G, Guillois R, Ory-Paoletti C, Gignoux M. Estimation of the familial relative risk of cancer by site from a french population based family study on colorectal cancer (CCREF study). Gut. 2004;53(9):1322–8.CrossRefPubMedPubMedCentral
15.
go back to reference Dixon LB, Balder HF, Virtanen MJ, Rashidkhani B, Männistö S, Krogh V, et al. Dietary patterns associated with colon and rectal cancer: results from the dietary patterns and Cancer (DIETSCAN) Project. Am J Clin Nutr. 2004;80(4):1003–11.CrossRefPubMed Dixon LB, Balder HF, Virtanen MJ, Rashidkhani B, Männistö S, Krogh V, et al. Dietary patterns associated with colon and rectal cancer: results from the dietary patterns and Cancer (DIETSCAN) Project. Am J Clin Nutr. 2004;80(4):1003–11.CrossRefPubMed
19.
go back to reference Swaroop VS, Winawer SJ, Kurtz RC, Lipkin M. Multiple primary malignant tumors. Gastroenterology. 1987;93(4):779–83.CrossRefPubMed Swaroop VS, Winawer SJ, Kurtz RC, Lipkin M. Multiple primary malignant tumors. Gastroenterology. 1987;93(4):779–83.CrossRefPubMed
24.
go back to reference Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of european randomized clinical trials. J Clin Oncol. 2011;29(23):3163–72. https://doi.org/10.1200/jco.2010.33.1595.CrossRefPubMed Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, et al. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of european randomized clinical trials. J Clin Oncol. 2011;29(23):3163–72. https://​doi.​org/​10.​1200/​jco.​2010.​33.​1595.CrossRefPubMed
28.
go back to reference van Gijn W, van Stiphout R, van de Velde CJH, Valentini V, Lammering G, Gambacorta MA, et al. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy. Ann Oncol. 2015;26(5):928–35. https://doi.org/10.1093/annonc/mdv023.CrossRefPubMed van Gijn W, van Stiphout R, van de Velde CJH, Valentini V, Lammering G, Gambacorta MA, et al. Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy. Ann Oncol. 2015;26(5):928–35. https://​doi.​org/​10.​1093/​annonc/​mdv023.CrossRefPubMed
Metadata
Title
Risk prediction of second primary malignancies in patients after rectal cancer: analysis based on SEER Program
Authors
Yong-Chao Sun
Zi-Dan Zhao
Na Yao
Yu-Wen Jiao
Jia-Wen Zhang
Yue Fu
Wei-Hai Shi
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02974-2

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.